Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells

British Journal of Pharmacology

Volumn 140, Issue 4, 2003, Pages 595-610

  Gerritsen, Mary E ^a,b   Tomlinson, James E ^a   Zlot, Constance ^a   Ziman, Michael ^a   Hwang, Stuart ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b NONE   (United States)

Author keywords

Angiogenesis; Endothelium; Gene expression; Hepatocyte growth factor; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 4; BONE MORPHOGENETIC PROTEIN 2; CELL PROTEIN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 8; NEU DIFFERENTIATION FACTOR; NEUROPILIN 1; PLATELET DERIVED GROWTH FACTOR A; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

EID: 0242492548     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705494     Document Type: Conference Paper

References (52)

1. ABE, M. & SATO, Y. (2001). cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis, 4, 289-298.
2. ASAHARA, T., BAUTERS, C., ZHENG, L.P., TAKESHIT, A.S., BUNTING, S., FERRARA, N., SYMES, J.F. & ISNER, J.M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation, 92, II365-II371.
3. ASHMAN, L.K. (1999). The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell. Biol., 31, 1037-1051.
4. BAFFOUR, R., BERMAN, J., GARB, J.L., RHEE, S.W., KAUFMAN, J. & FRIEDMANN, P. (1992). Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia:dose-response effect of basic fibroblast growth factor. J. Vasc. Surg., 16, 181-191.
5. BAFFOUR, R., GARB, J.L., KAUFMAN, J., BERMAN, J., RHEE, S.W., NORRIS, M.A. & FRIEDMANN, P. (2000). Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J. Surg. Res., 93, 219-229.
6. BAUMGARTNER, I. & ISNER, J.M. (1998). Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). Vasa, 27, 201-206.
7. BELL, S.E., MAVILA, A., SALAZAR, R., BAYLESS, K.J., KANAGALA, S., MAXWELL, S.A. & DAVIS, G.E. (2001). Differential gene expression during capillary morphogenesis in 3D collagen matrices:regulated expression of genes involved in basement membrane matrix assembly,cell cycle progression,cellular differentiation and G-protein signaling. J. Cell Sci., 114, 2755-2773.
8. BENDALL, L.J., MAKRYNIKOLA, V., HUTCHINSON, A., BIANCHI, A.C., BRADSTOCK, K.F. & GOTTLIEB, D.J. (1998). Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals. Leukemia, 12, 1375-1382.
9. BUSH, R.L., PEVEC, W.C., NDOYE, A., CHEUNG, A.T., SASSE, J. & PEARSON, D.N. (1998). Regulation of new blood vessel growth into ischemic skeletal muscle. J. Vasc. Surg., 28, 919-928.
10. BUSSOLINO, F., DI RENZO, M.F., ZICHE, M., BOCCHIETTO, E., OLIVERO, M., NALDINI, L., GAUDINO, G., TAMAGNONE, L., COFFER, A. & COMOGLIO, P.M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119, 629-641.
11. CHLEBOUN, J.O. & MARTINS, R.N. (1994). The development and enhancement of the collateral circulation in an animal model of lower limb ischaemia. Aust. NZJ. Surg., 64, 202-207.
12. DUARTE, R.F. & FRANF, D.A. (2002). The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF):molecular basis and clinical relevance. Leuk. Lymphoma, 43, 1179-1187.
13. FERRARA, N. (1999). Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int., 56, 794-814.
14. FERRARA, N. & ALITALO, K. (1999). Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med., 5, 1359-1364.
15. GERRITSEN, M., SORIANO, R., YANG, S., ZLOT, C., INGLE, G., TOY, K. & WILLIAMS, P. (2003). Branching out: a molecular fingerprint generated by Affymetrix Oligonucleotide arrays. Microcirculation, 10, 63-81.
16. GERRITSEN, M.E., SORIANO, R., YANG, S., INGLE, G., ZLOT, C., TOY, K., WINER, J., DRAKSHARAPU, A., PEALE, F., WU, T.D. & WILLIAMS, P.M. (2002). In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol. Genomics, 10, 13-20.
17. HAYASHI, S., MORISHITA, R., NAKAMURA, S., YAMAMOTO, K., MORIGUCHI, A., NAGANO, T., TAIJI, M., NOGUCHI, H., MATSUMOTO, K., NAKAMURA, T., HIGAKI, J. & OGIHARA, T. (1999). Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease:downregulation of HGF in response to hypoxia in vascular cells. Circulation, 100, II301-II308.
18. HEIKE, T. & NAKAHATA, T. (2002). Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim. Biophys. Acta, 1592, 313-321.
19. HENRY, T.D., ANNEX, B.H., MCKENDALL, G.R., AZRIN, M.A., LOPEZ, J.J., GIORDANO, F.J., SHAH, P.K., WILLERSON, J.T., BENZA, R.L., BERMAN, D.S., GIBSON, C.M., BAJAMONDE, A., RUNDLE, A.C., FINE, J. & MCCLUSKEY, E.R. (2003). The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation, 107, 1359-1365.
20. JIANG, W.G., MARTIN, T.A., MATSUMOTO, K., NAKAMURA, T. & MANSEL, R.E. (1999). Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J. Cell Physiol., 181, 319-329.
21. KAHN, J., MEHRABAN, F., INGLE, G., XIN, X., BRYANT, J., VEHAR, G., SCHOENFELD, J., GRIMALDI, C., PEALE, F., DRAKHARAPU, A., LEWIN, D. & GERRITSEN, M. (2000). Gene expression profiling in an in vitro model of angiogenesis. Am. J. Pathol., 156, 1887-1900.
22. KHAN, T.A., SELLKE, F.W. & LAHAM, R.J. (2003). Therapeutic angiogenesis:protein-based therapy for coronary artery disease. Expert Opin. Pharmacother., 4, 219-226.
23. KIM, I., KIM, J.H., MOON, S.O., KWAK, H.J., KIM, N.G. & KOH, G.Y. (2000). Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene, 19, 4549-4552.
24. LAZAROUS, D.F., UNGER, E.F., EPSTEIN, S.E., STINE, A., AREVALO, J.L., CHEW, E.Y. & QUYYUMI, A.A. (2000). Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J. Am. Coll. Cardiol., 36, 1239-1244.
25. LAZZARI, L., LUCCHI, S., REBULLA, P., PORRETTI, L., PUGLISI, G., LECCHI, L. & SIRCHIA, G. (2001). Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br. J. Haematol., 112, 397-404.
26. MITSUNARI, M., HARADA, T., TANIKAWA, M., IWABE, T., TANIGUCHI, F. & TERAKAWA, N. (1999). The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation. Mol. Hum. Reprod., 5, 874-879.
27. MOMOSE, K., TAGUCHI, K., SAITOH, M., YASUDA, S. & MIYATA, K. (2002). Effects of interleukin-11 on the hematopoietic action of granulocyte colony-stimulating factor. Arzneimittelforschung, 52, 857-861.
28. MORIMOTO, A., OKAMURA, K., HAMANAKA, R., SATO, Y., SHIMA, N., HIGASHIO, K. & KUWANO, M. (1991). Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. Biochem. Biophys. Res. Commun., 179, 1042-1049.
29. NAKAMURA, Y., MORISHITA, R., HIGAKI, J., KIDA, I., AOKI, M., MORIGUCHI, A., YAMADA, K., HAYASHI, S., YO, Y., NAKANO, H., MATSUMOTO, K., NAKAMURA, T. & OGIHARA, T. (1996). Hepatocyte growth factor is a novel member of the endothelium-specific growth factors:additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J. Hypertens., 14, 1067-1072.
30. NANDURKAR, H.H., ROBB, L. & BEGLEY, G.G. (1998). The role of IL-II in hematopoiesis as revealed by a targeted mutation of its receptor. Stem Cells, 16, 53-65.
31. OH, I.S., SO, S.S., JAHNG, K.Y. & KIM, H.G. (2002). Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 296, 401-405.
32. PEPPER, M.S., FERRARA, N., ORCI, L. & MONTESANO, R. (1992). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189, 824-831.
33. PESCE, M., DI CARLO, A. & DE FELICI, M. (1997). The c-kit receptor is involved in the adhesion of mouse primordial germ cells to somatic cells in culture. Mech. Dev., 68, 37-44.
34. RECIO, J.A. & MERLINO, G. (2003). Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res., 63, 1576-1582.
35. ROBERTS, C.J., NELSON, B., MARTON, M.J., STOUGHTON, R., MEYER, M.R., BENNETT, H.A., HE, Y.D., DAI, H., WALKER, W.L., HUGHES, T.R., TYERS, M., BOONE, C. & FRIEND, S.H. (2000). Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science, 287, 873-880.
36. ROSEN, E.M., LAMSZUS, K., LATERRA, J., POLVERINI, P.J., RUBIN, J.S. & GOLDBERG, I.D. (1997). HGF/SF in angiogenesis. Ciba Found. Symp., 212, 215-226 (discussion 227-229).
37. SATCHELL, S.C. & MATHIESON, P.W. (2003). Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology. J. Nephrol., 16, 168-178.
38. SCHADT, E.E., LI, C., ELLIS, B. & WONG, W.H. (2002). Feature extraction and normalization algorithm for high-density oligonucleotide gene expression array data. J. Cell. Biochem., 84, 120-125.
39. SENGUPTA, S., GHERARDI, E., SELLERS, L.A., WOOD, J.M., SASISEKHARAN, R. & FAN, T.P. (2003). Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol., 23, 69-75.
40. SHIMIZU, M., MINAKUCHI, K., TSUDA, A., HIROI, T., TANAKA, N., KOGA, J. & KIYONO, H. (2001). Role of stem cell factor and c-kit signaling in regulation of fetal intestinal epithelial cell adhesion to fibronectin. Exp. Cell Res., 266, 311-322.
41. SMITH, M.A., COURT, E.L. & SMITH, J.G. (2001). Stem cell factor: laboratory and clinical aspects. Blood Rev., 15, 191-197.
42. STARK, J., BAFFOUR, R., GARB, J.L., KAUFMAN, J., BERMAN, J., RHEE, S., NORRIS, M.A. & FRIEDMANN, P. (1998). Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats. J. Surg. Res., 79, 8-12.
43. STOUGHTON, R. & DAI, H. (2002). Statistical combining of cell expression profiles. US Patent No.6, 351, 712.
44. TOMITA, N., MORISHITA, R., TANIYAMA, Y., KOIKE, H., AOKI, M., SHIMIZU, H., MATSUMOTO, K., NAKAMURA, T., KANEDA, Y. & OGIHARA, T. (2003). Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation, 107, 1411-1417.
45. TURNER, K.J., NEBEN, S., WEICH, N., SCHAUB, R.G. & GOLDMAN, S.J. (1996). The role of recombinant interleukin 11 in megakaryocytopoiesis. Stem Cells, 14, 53-61.
46. VAN BELLE, E., WITZENBICHLER, B., CHEN, D., SILVER, M., CHANG, L., SCHWALL, R. & ISNER, J.M. (1998). Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation, 97, 381-390.
47. VEIKKOLA, T. & ALITALO, K. (2002). Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis. Dev. Cell, 3, 302-304.
48. WOJTA, J., KAUN, C., BREUSS, J.M., KOSHELNICK, Y., BECKMANN, R., HATTEY, E., MILDNER, M., WENINGER, W., NAKAMURA, T., TSCHACHLER, E. & BINDER, B.R. (1999). Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest., 79, 427-438.
49. XIN, X., YANG, S., INGLE, G., ZLOT, C., RANGELL, L., KOWALSKI, J., SCHWALL, R., FERRARA, N. & GERRITSEN, M.E. (2001). Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol., 158, 1111-1120.
50. YANG, H.T. & FENG, Y. (2000). bFGF increases collateral blood flow in aged rats with femoral artery ligation. Am. J. Physiol. Heart Circ. Physiol., 278, H85-H93.
51. YANG, S., TOY, K., INGLE, G., ZLOT, C., WILLIAMS, P.M., FUH, G., LI, B., DE VOS, A. & GERRITSEN, M.E. (2002). Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells:relative roles of KDR and Flt-1 receptors. Arterioscler. Thromb. Vasc. Biol., 22, 1797-1803.
52. ZHU, H., LI, J., QIN, W., YANG, Y., HE, X., WAN, D. & GU, J. (2002). Cloning of a novel gene, ANGPTL4 and the functional study in angiogenesis. Zhonghua Yi Xue Za Zhi, 82, 94-99.